Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment

Philip JT Reardon,1,* Maryam Parhizkar,2,* Anthony H Harker,3 Richard J Browning,4 Vessela Vassileva,5 Eleanor Stride,4 R Barbara Pedley,5 Mohan Edirisinghe,2 Jonathan C Knowles1 1Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, 2Department of Mechanical Engineering, 3...

Full description

Bibliographic Details
Main Authors: Reardon PJT, Parhizkar M, Harker AH, Browning RJ, Vassileva V, Stride E, Pedley RB, Edirisinghe M, Knowles JC
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/electrohydrodynamic-fabrication-of-core-shell-plga-nanoparticles-with-peer-reviewed-article-IJN
_version_ 1819202801489674240
author Reardon PJT
Parhizkar M
Harker AH
Browning RJ
Vassileva V
Stride E
Pedley RB
Edirisinghe M
Knowles JC
author_facet Reardon PJT
Parhizkar M
Harker AH
Browning RJ
Vassileva V
Stride E
Pedley RB
Edirisinghe M
Knowles JC
author_sort Reardon PJT
collection DOAJ
description Philip JT Reardon,1,* Maryam Parhizkar,2,* Anthony H Harker,3 Richard J Browning,4 Vessela Vassileva,5 Eleanor Stride,4 R Barbara Pedley,5 Mohan Edirisinghe,2 Jonathan C Knowles1 1Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, 2Department of Mechanical Engineering, 3Department of Physics & Astronomy, University College London, London, 4Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, 5Department of Oncology, UCL Cancer Institute, University College London, London, UK *These authors contributed equally to this work Abstract: Increasing the clinical efficacy of toxic chemotherapy drugs such as cisplatin (CDDP), via targeted drug delivery, is a key area of research in cancer treatment. In this study, CDDP-loaded poly(lactic-co-glycolic acid) (PLGA) polymeric nanoparticles (NPs) were successfully prepared using electrohydrodynamic atomization (EHDA). The configuration was varied to control the distribution of CDDP within the particles, and high encapsulation efficiency (>70%) of the drug was achieved. NPs were produced with either a core–shell (CS) or a matrix (uniform) structure. It was shown that CS NPs had the most sustained release of the 2 formulations, demonstrating a slower linear release post initial “burst” and longer duration. The role of particle architecture on the rate of drug release in vitro was confirmed by fitting the experimental data with various kinetic models. This indicated that the release process was a simple diffusion mechanism. The CS NPs were effectively internalized into the endolysosomal compartments of cancer cells and demonstrated an increased cytotoxic efficacy (concentration of a drug that gives half maximal response [EC50] reaching 6.2 µM) compared to free drug (EC50 =9 µM) and uniform CDDP-distributed NPs (EC50 =7.6 µM) in vitro. Thus, these experiments indicate that engineering the structure of PLGA NPs can be exploited to control both the dosage and the release characteristics for improved clinical chemotherapy treatment. Keywords: cisplatin, drug delivery, cancer chemotherapy, polymer, poly(lactic-co-glycolic acid), nanoparticles, electrohydrodynamic atomization, controlled release
first_indexed 2024-12-23T04:09:48Z
format Article
id doaj.art-c5577a17a8564e8d97fd258cd03393fe
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-23T04:09:48Z
publishDate 2017-05-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-c5577a17a8564e8d97fd258cd03393fe2022-12-21T18:00:32ZengDove Medical PressInternational Journal of Nanomedicine1178-20132017-05-01Volume 123913392633000Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatmentReardon PJTParhizkar MHarker AHBrowning RJVassileva VStride EPedley RBEdirisinghe MKnowles JCPhilip JT Reardon,1,* Maryam Parhizkar,2,* Anthony H Harker,3 Richard J Browning,4 Vessela Vassileva,5 Eleanor Stride,4 R Barbara Pedley,5 Mohan Edirisinghe,2 Jonathan C Knowles1 1Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, 2Department of Mechanical Engineering, 3Department of Physics & Astronomy, University College London, London, 4Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, 5Department of Oncology, UCL Cancer Institute, University College London, London, UK *These authors contributed equally to this work Abstract: Increasing the clinical efficacy of toxic chemotherapy drugs such as cisplatin (CDDP), via targeted drug delivery, is a key area of research in cancer treatment. In this study, CDDP-loaded poly(lactic-co-glycolic acid) (PLGA) polymeric nanoparticles (NPs) were successfully prepared using electrohydrodynamic atomization (EHDA). The configuration was varied to control the distribution of CDDP within the particles, and high encapsulation efficiency (>70%) of the drug was achieved. NPs were produced with either a core–shell (CS) or a matrix (uniform) structure. It was shown that CS NPs had the most sustained release of the 2 formulations, demonstrating a slower linear release post initial “burst” and longer duration. The role of particle architecture on the rate of drug release in vitro was confirmed by fitting the experimental data with various kinetic models. This indicated that the release process was a simple diffusion mechanism. The CS NPs were effectively internalized into the endolysosomal compartments of cancer cells and demonstrated an increased cytotoxic efficacy (concentration of a drug that gives half maximal response [EC50] reaching 6.2 µM) compared to free drug (EC50 =9 µM) and uniform CDDP-distributed NPs (EC50 =7.6 µM) in vitro. Thus, these experiments indicate that engineering the structure of PLGA NPs can be exploited to control both the dosage and the release characteristics for improved clinical chemotherapy treatment. Keywords: cisplatin, drug delivery, cancer chemotherapy, polymer, poly(lactic-co-glycolic acid), nanoparticles, electrohydrodynamic atomization, controlled releasehttps://www.dovepress.com/electrohydrodynamic-fabrication-of-core-shell-plga-nanoparticles-with-peer-reviewed-article-IJNcisplatindrug deliverycancer chemotherapypolymerPoly (lactic-co-glycolic acidnanoparticleselectrohydrodynamic atomizationcontrolled release
spellingShingle Reardon PJT
Parhizkar M
Harker AH
Browning RJ
Vassileva V
Stride E
Pedley RB
Edirisinghe M
Knowles JC
Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
International Journal of Nanomedicine
cisplatin
drug delivery
cancer chemotherapy
polymer
Poly (lactic-co-glycolic acid
nanoparticles
electrohydrodynamic atomization
controlled release
title Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
title_full Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
title_fullStr Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
title_full_unstemmed Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
title_short Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
title_sort electrohydrodynamic fabrication of core ndash shell plga nanoparticles with controlled release of cisplatin for enhanced cancer treatment
topic cisplatin
drug delivery
cancer chemotherapy
polymer
Poly (lactic-co-glycolic acid
nanoparticles
electrohydrodynamic atomization
controlled release
url https://www.dovepress.com/electrohydrodynamic-fabrication-of-core-shell-plga-nanoparticles-with-peer-reviewed-article-IJN
work_keys_str_mv AT reardonpjt electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT parhizkarm electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT harkerah electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT browningrj electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT vassilevav electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT stridee electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT pedleyrb electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT edirisinghem electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment
AT knowlesjc electrohydrodynamicfabricationofcorendashshellplgananoparticleswithcontrolledreleaseofcisplatinforenhancedcancertreatment